$456 Million is the total value of Aviva Holdings Ltd.'s 9 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 14.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRTX | MIRATI THERAPEUTICS INC | $229,866,000 | +72.8% | 3,135,966 | 0.0% | 50.43% | +20.2% | |
MDCO | MEDICINES CO | $105,616,000 | +46.0% | 3,778,742 | 0.0% | 23.17% | +1.6% | |
INSG | INSEEGO CORP | $88,732,000 | +13.7% | 18,799,229 | 0.0% | 19.47% | -20.9% | |
ESPR | Sell | ESPERION THERAPEUTICS INC NE | $17,732,000 | -17.0% | 441,649 | -4.9% | 3.89% | -42.3% |
INSEEGO CORPnote 5.500% 6/1 | $13,758,000 | +13.7% | 13,700,000 | 0.0% | 3.02% | -20.9% | ||
SLDB | SOLID BIOSCIENCES INC. | $106,000 | -65.6% | 11,488 | 0.0% | 0.02% | -76.3% | |
MGNX | Exit | MACROGENICS INC. | $0 | – | -3,815 | -100.0% | -0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Braslyn Ltd. #1
- Avid Group Ltd. #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 100.0% |
INSEEGO CORP | 21 | Q3 2023 | 39.6% |
INSEEGO CORP | 14 | Q3 2023 | 10.2% |
PAMPA ENERGIA SA ADR | 12 | Q3 2022 | 26.0% |
MEDICINES CO | 11 | Q3 2019 | 87.4% |
ESPERION THERAPEUTICS INC NE | 9 | Q1 2019 | 14.2% |
TANGO THERAPEUTICS INC. | 9 | Q3 2023 | 0.2% |
SOLID BIOSCIENCES INC. | 9 | Q2 2020 | 0.1% |
INSEEGO CORP | 8 | Q1 2020 | 41.4% |
MACROGENICS INC. | 6 | Q4 2018 | 10.0% |
View Aviva Holdings Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Aviva Holdings Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.